SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Barclays Maintains Equal-Weight on Neurocrine Biosciences, Raises Price Target to $108

Barclays maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Equal-Weight and raises the price target from $105 to $108.

Benzinga · 05/07/2020 15:01

Barclays maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Equal-Weight and raises the price target from $105 to $108.